Designing for a longer life: the future of longevity cities
Deep Knowledge Group - 09-Apr-2025How AI and biosensors are reshaping urban design for health and longevity
Join the club for FREE to access the whole archive and other member benefits.
Artificial intelligence (AI) is revolutionising healthcare and drug discovery, bringing unprecedented advancements to both fields.
In healthcare, AI is transforming medical imaging and diagnostics. By analysing X-rays, MRIs, and other scans, AI can detect conditions like tumours and fractures more quickly and accurately than ever before. This technology also extends to pathology, where AI can identify cancerous cells in tissue samples with remarkable precision.
Though the data scientists need to make sure they feed in the right data. For example, in a study designed to detect hip fractures, it turned out the AI was using the patient's age and particularly the imaging device model to make its prediction. This worked because portable scanners are only used then the patient is too immobile to get to a hospital - and this limitation turned out to be a bigger indicator than any details on the image itself.
In drug discovery, AI accelerates the process by predicting the structure and properties of new molecules, identifying potential drug candidates faster than traditional methods. AI helps repurpose existing drugs for new uses, reducing the time and cost of bringing new treatments to market. By predicting drug interactions and side effects, AI ensures safer medications for patients. In genomics and proteomics, AI analyses vast amounts of data to uncover new drug targets and understand disease mechanisms, paving the way for innovative treatments.
Additionally, AI plays a crucial role in biomarker discovery, which is essential for diagnosing diseases and monitoring treatment responses. Clinical trials also benefit from AI through better patient selection and real-time monitoring, making trials more efficient. And finally, AI is pivotal in predictive analytics, monitoring patients' data from wearable devices and electronic health records to predict and prevent health issues before they become critical.
How AI and biosensors are reshaping urban design for health and longevity
Dartmouth’s chatbot reduces symptoms using cognitive behavioural therapy in a clinical trial
Backed by Nobel science, the Alphabet spinout speeds up AI drug development
UK study shows AI speeds up 20-week scans and boosts accuracy and care
Click on resource name for more details.
02-Apr-2025
Buck’s Levy Community Seminar, supported by a William and Elisabeth Levy (FREE, California, USA)
26-Feb-2025
London Longevity online webinar with Professor Ronjon Nag
Ben Goertzel delivered a keynote on AI and Decentralised Science in Longevity Research
The biology of ageing looks at way more than just the genome and microbiome - here's 20 to start with!
Algocyte platform uses algorithmic inverse problem solving to aid clinicians in their diagnosis